A Big Leap For E-Pedigree Standards, Technologies
For years, the Food and Drug Administration ("FDA") has recommended that pharmaceutical companies employ radiofrequency identification ("RFID") or other technology to create an e-pedigree that would effectively fight the rampant drug counterfeiting problem.
But due to costs, lack of standards, and other concerns, drug companies have not implemented the FDA's proposal on a widespread basis.
That is about to change.
To view the full article, register now.